155 related articles for article (PubMed ID: 20374646)
1. STAMP alters the growth of transformed and ovarian cancer cells.
He Y; Blackford JA; Kohn EC; Simons SS
BMC Cancer; 2010 Apr; 10():128. PubMed ID: 20374646
[TBL] [Abstract][Full Text] [Related]
2. STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression.
He Y; Simons SS
Mol Cell Biol; 2007 Feb; 27(4):1467-85. PubMed ID: 17116691
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Ttll5/stamp gene (tubulin tyrosine ligase-like protein 5/SRC-1 and TIF2-associated modulatory protein gene) in male mice causes sperm malformation and infertility.
Lee GS; He Y; Dougherty EJ; Jimenez-Movilla M; Avella M; Grullon S; Sharlin DS; Guo C; Blackford JA; Awasthi S; Zhang Z; Armstrong SP; London EC; Chen W; Dean J; Simons SS
J Biol Chem; 2013 May; 288(21):15167-80. PubMed ID: 23558686
[TBL] [Abstract][Full Text] [Related]
4. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
Bolitho C; Hahn MA; Baxter RC; Marsh DJ
Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723
[TBL] [Abstract][Full Text] [Related]
5. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
[TBL] [Abstract][Full Text] [Related]
6. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
7. Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.
Awasthi S; Simons SS
Mol Cell Endocrinol; 2012 May; 355(1):121-34. PubMed ID: 22342989
[TBL] [Abstract][Full Text] [Related]
8. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
Meng Y; Gu C; Wu Z; Zhao Y; Si Y; Fu X; Han W
BMC Cancer; 2009 Mar; 9():75. PubMed ID: 19257909
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
10. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
Reimer D; Hubalek M; Riedle S; Skvortsov S; Erdel M; Concin N; Fiegl H; Müller-Holzner E; Marth C; Illmensee K; Altevogt P; Zeimet AG
Cancer Res; 2010 Jun; 70(11):4613-23. PubMed ID: 20460525
[TBL] [Abstract][Full Text] [Related]
11. Expression of PKG2 in ovarian cancer and its effect on epidermal growth factor receptor.
Xu H; Zhang Z; Li P; Lu X; Chen B; Lan T
J BUON; 2020; 25(2):729-735. PubMed ID: 32521860
[TBL] [Abstract][Full Text] [Related]
12. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
13. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
14. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.
Chao TK; Yo YT; Liao YP; Wang YC; Su PH; Huang TS; Lai HC
Gynecol Oncol; 2013 Mar; 128(3):475-82. PubMed ID: 23270808
[TBL] [Abstract][Full Text] [Related]
15. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
17. [Biological effects of down-regulating of TIZ gene on ovarian cancer cells in vitro].
Zhao BB; Zhang W; Yang ZJ; Wang Q; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):781-6. PubMed ID: 23302738
[TBL] [Abstract][Full Text] [Related]
18. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation.
He Y; Szapary D; Simons SS
J Biol Chem; 2002 Dec; 277(51):49256-66. PubMed ID: 12376547
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
20. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.
Agarwal R; D'Souza T; Morin PJ
Cancer Res; 2005 Aug; 65(16):7378-85. PubMed ID: 16103090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
